Table 1 Baseline characteristics
Characteristics |  | FAS (n = 35) | Safety/surgery set (n = 32) |
|---|---|---|---|
Age (years), median (range) | Â | 62 (35, 73) | 60 (35, 73) |
Gender, n (%) | Male | 27 (77.1%) | 26 (81.2%) |
Female | 8 (22.9%) | 6 (18.8%) | |
ECOG PS, n (%) | 0–1 | 35 (100%) | 32 (100%) |
Tumor location, n (%) | Stomach | 24 (68.6%) | 21 (65.6%) |
GEJ | 11 (31.4%) | 11 (34.4%) | |
Histology, n (%) | Differentiated type | 11 (31.4%) | 10 (31.2%) |
Undifferentiated type | 22 (62.9%) | 21 (65.6%) | |
NOS | 2 (5.7%) | 1 (3.1%) | |
Lauren subtype, n (%) | Intestinal | 18 (51.4%) | 17 (53.1%) |
Mixed | 4 (11.4%) | 4 (12.5%) | |
Diffuse | 8 (22.9%) | 8 (25.0%) | |
Unknown | 5 (14.3%) | 3 (9.4%) | |
Clinical tumor stage, n (%) | cT3 | 8 (22.9%) | 8 (25.0%) |
cT4a | 27 (77.1%) | 24 (75.0%) | |
Clinical node stage, n (%) | cN1 | 11 (31.4%) | 11 (34.4%) |
cN2 | 21 (60.0%) | 20 (62.5%) | |
cN3 | 3 (8.6%) | 1 (3.1%) |